PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients
Authors:
- 1 February 2001
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 154 (3) , 641-649
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A Frequent Mutation in the Lipoprotein Lipase Gene (D9N) Deteriorates the Biochemical and Clinical Phenotype of Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Angiotensin-converting enzyme and cardiovascular disease riskCurrent Opinion in Lipidology, 1999
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993
- Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Antioxidative activity of high density lipoproteins in vivoAtherosclerosis, 1993
- Role of oxidized low density lipoprotein in atherogenesis.Journal of Clinical Investigation, 1991
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991
- Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoproteinFEBS Letters, 1991
- Beyond CholesterolNew England Journal of Medicine, 1989
- Family similarities in the age at coronary death in familial hypercholesterolaemia.BMJ, 1977